Endothelial cell heterogeneity

Cold Spring Harbor Perspectives in Medicine

Volumn 2, Issue 1, 2012, Pages

  Aird, William C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN RECEPTOR; ANTICOAGULANT AGENT; ANTIINFECTIVE AGENT; ANTITHROMBIN III; CD31 ANTIGEN; CLAUDIN 5; COLLAGEN; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERCELLULAR ADHESION MOLECULE 1; JUNCTIONAL ADHESION MOLECULE A; LIPOCORTIN 1; PADGEM PROTEIN; PROCOAGULANT; PROSTATE SPECIFIC MEMBRANE ANTIGEN; PROTEIN C; PROTEIN P53; PROTEIN S; ROBO4 GENE; THROMBOSPONDIN 1; TRANSCRIPTOME; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN RECEPTOR 2; VERY LATE ACTIVATION ANTIGEN 5; VITRONECTIN RECEPTOR; ANGIOGENESIS INHIBITOR;

ARTICLE; BLOOD BRAIN BARRIER; BLOOD VESSEL; CANCER RADIOTHERAPY; CANCER RISK; CELL DIFFERENTIATION; CELL HETEROGENEITY; CELL MIGRATION; CELL PROLIFERATION; DNA SEQUENCE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; EPIGENETICS; FENESTRATION; FLUID TRANSPORT; GENE EXPRESSION; HEMODYNAMIC STRESS; HEMOSTASIS; HISTONE ACETYLATION; HUMAN; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEOMICS; TRANSCYTOSIS; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; VASCULAR TUMOR; VENULE; WNT SIGNALING PATHWAY; EVOLUTION; GENETICS; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ANGIOGENESIS INHIBITORS; BIOLOGICAL EVOLUTION; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PHENOTYPE;

EID: 84869091543     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a006429     Document Type: Article

References (72)

1. Aird WC. 2001. Vascular bed-specific hemostasis: Role of endothelium in sepsis pathogenesis. Crit Care Med 29: S28-S35.
2. Aird WC. 2006. Mechanisms of endothelial cell heterogeneity in health and disease. Circ Res 98: 159-162.
3. Aird WC. 2007a. Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res 100: 158-173.
4. Aird WC. 2007b. Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ Res 100: 174-190.
5. Aird WC. 2009. Molecular heterogeneity of tumor endothelium. Cell Tissue Res 335: 271-281.
6. Aitsebaomo J, Portbury AL, Schisler JC, Patterson C. 2008. Brothers and sisters: Molecular insights into arterial-venous heterogeneity. Circ Res 103: 929-939.
7. Arap W, Pasqualini R, Ruoslahti E. 1998. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 279: 377-380.
8. Arap W, Haedicke W, Bernasconi M, Kain R, Rajotte D, Krajewski S, Ellerby HM, Bredesen DE, Pasqualini R, Ruoslahti E. 2002a. Targeting the prostate for destruction through a vascular address. Proc Natl Acad Sci 99: 1527-1531.
9. Arap W, Kolonin MG, Trepel M, Lahdenranta J, Cardo-Vila M, Giordano RJ, Mintz PJ, Ardelt PU, Yao VJ, Vidal CI, et al. 2002b. Steps toward mapping the human vasculature by phage display. Nat Med 8: 121-127.
10. Aurrand-Lions M, Johnson-Leger C, Imhof BA. 2002. The last molecular fortress in leukocyte trans-endothelial migration. Nat Immunol 3: 116-118.
11. Barnes CM, Huang S, Kaipainen A, Sanoudou D, Chen EJ, Eichler GS, Guo Y, YuY, Ingber DE, Mulliken JB, et al. 2005. Evidence by molecular profiling for a placental origin of infantile hemangioma. Proc Natl Acad Sci 102: 19097-19102.
12. Basit A, Reutershan J, Morris MA, Solga M, Rose CE Jr., Ley K. 2006. ICAM-1 and LFA-1 play critical roles in LPS-induced neutrophil recruitment into the alveolar space. Am J Physiol Lung Cell Mol Physiol 291: L200-L207.
13. Bendayan M. 2002. Morphological and cytochemical aspects of capillary permeability. Microsc Res Tech 57: 327-349.
14. Boye E, Yu Y, Paranya G, Mulliken JB, Olsen BR, Bischoff J. 2001. Clonality and altered behavior of endothelial cells from hemangiomas. J Clin Invest 107: 745-752.
15. Burridge KA, Friedman MH. 2010. Environment and vascular bed origin influence differences in endothelial transcriptional profiles of coronary and iliac arteries. Am J Physiol Heart Circ Physiol 299: H837-H846.
16. Bussolati B, Deambrosis I, Russo S, Deregibus MC, Camussi G. 2003. Altered angiogenesis and survival in human tumor-derived endothelial cells. FASEB J 17: 1159-1161.
17. Butcher EC. 1991. Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity. Cell 67: 1033-1036.
18. Chi JT, Chang HY, Haraldsen G, Jahnsen FL, Troyanskaya OG, Chang DS, WangZ, Rockson SG, van de Rijn M, Botstein D, et al. 2003. Endothelial cell diversity revealed by global expression profiling. Proc Natl Acad Sci 100: 10623-10628.
19. Denekamp J, Hobson B. 1982. Endothelial-cell proliferation in experimental tumours. Br J Cancer 46: 711-720.
20. Dvorak AM, Feng D. 2001. The vesiculo-vacuolar organelle (VVO). A new endothelial cell permeability organelle. J Histochem Cytochem 49: 419-432.
21. Fathers KE, Stone CM, Minhas K, Marriott JJ, Greenwood JD, Dumont DJ, Coomber BL. 2005. Heterogeneity of Tie2 expression in tumor microcirculation: Influence of cancer type, implantation site, and response to therapy. Am J Pathol 167: 1753-1762.
22. Feng J, Yano K, Monahan-Earley R, Morgan ES, Dvorak AM, Sellke FW, Aird WC. 2007. Vascular bed-specific endothelium-dependent vasomomotor relaxation in the hagfish, Myxine glutinosa. Am J Physiol Regul Integr Comp Physiol 293: R894-R900.
23. Flaherty JT, Pierce JE, Ferrans VJ, Patel DJ, Tucker WK, Fry DL. 1972. Endothelial nuclear patterns in the canine arterial tree with particular reference to hemodynamic events. Circ Res 30: 23-33.
24. Folkman J. 1971. Tumor angiogenesis: Therapeutic implications. N Engl J Med 285: 1182-1186.
25. Franco CA, Liebner S, Gerhardt H. 2009. Vascular morphogenesis: A Wnt for every vessel? Curr Opin Genet Dev 19: 476-483.
26. Franses JW, Baker AB, Chitalia VC, Edelman ER. 2011. Stromal endothelial cells directly influence cancer progression. Sci Transl Med 3: 66ra5.
27. Fukumura D, Yuan F, Monsky WL, Chen Y, Jain RK. 1997. Effect of host microenvironment on the microcirculation of human colon adenocarcinoma. Am J Pathol 151: 679-688.
28. Goymer P. 2008. Natural selection: The evolution of cancer. Nature 454: 1046-1048.
29. Hellebrekers DM, Castermans K, Vire E, Dings RP, Hoebers NT, Mayo KH, Oude Egbrink MG, Molema G, Fuks F, van Engeland M, et al. 2006a. Epigenetic regulation of tumor endothelial cell anergy: Silencing of intercellular adhesion molecule-1 by histone modifications. Cancer Res 66: 10770-10777.
30. Hellebrekers DM, Jair KW, Vire E, Eguchi S, Hoebers NT, Fraga MF, Esteller M, Fuks F, Baylin SB, van Engeland M, et al. 2006b. Angiostatic activity of DNA methyltransferase inhibitors. Mol Cancer Ther 5: 467-475.
31. Hellebrekers DM, Melotte V, Vire E, Langenkamp E, Molema G, Fuks F, HermanJG, Van Criekinge W, Griffioen AW, van Engeland M. 2007. Identification of epigenetically silenced genes in tumor endothelial cells. Cancer Res 67: 4138-4148.
32. Hida K, Hida Y, Amin DN, Flint AF, Panigrahy D, Morton CC, Klagsbrun M. 2004. Tumor-associated endothelial cells with cytogenetic abnormalities. Cancer Res 64: 8249-8255.
33. Hinnen P, Eskens FA. 2007. Vascular disrupting agents in clinical development. Br J Cancer 96: 1159-1165.
34. Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, Zagzag D, Yancopoulos GD, Wiegand SJ. 1999. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284: 1994-1998.
35. Hwa C, Sebastian A, Aird WC. 2005. Endothelial biomedicine: Its status as an interdisciplinary field, its progress as a basic science, and its translational bench-to-bedside gap. Endothelium 12: 139-151.
36. Keunen O, Johansson M, Oudin A, Sanzey M, Rahim SA, Fack F, Thorsen F, TaxtT, Bartos M, Jirik R, et al. 2011. Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma. Proc Natl Acad Sci 108: 3749-3754.
37. Lacorre DA, Baekkevold ES, Garrido I, Brandtzaeg P, Haraldsen G, Amalric F, Girard JP. 2004. Plasticity of endothelial cells: Rapid dedifferentiation of freshly isolated high endothelial venule endothelial cells outside the lymphoid tissue microenvironment. Blood 103: 4164-4172.
38. Laszik Z, Mitro A, Taylor FB Jr., Ferrell G, Esmon CT. 1997. Human protein C receptor is present primarily on endothelium of large blood vessels: Implications for the control of the protein C pathway. Circulation 96: 3633-3640.
39. Levin EG, Banka CL, Parry GC. 2000. Progressive and transient expression of tissue plasminogen activator during fetal development. Arterioscler Thromb Vasc Biol 20: 1668-1674.
40. Liu Z, Turkoz A, Jackson EN, Corbo JC, Engelbach JA, Garbow JR, Piwnica-Worms DR, Kopan R. 2011. Notch1 loss of heterozygosity causes vascular tumors and lethal hemorrhage in mice. J Clin Invest 121: 800-808.
41. McIntosh DP, Tan XY, Oh P, Schnitzer JE. 2002. Targeting endothelium and its dynamic caveolae for tissue-specific transcytosis in vivo: A pathway to overcome cell barriers to drug and gene delivery. Proc Natl Acad Sci 99: 1996-2001.
42. Merlo LM, Pepper JW, Reid BJ, Maley CC. 2006. Cancer as an evolutionary and ecological process. Nat Rev Cancer 6: 924-935.
43. Minami T, Aird WC. 2005. Endothelial cell gene regulation. Trends Cardiovasc Med 15: 174-184.
44. Miyasaka M, Tanaka T. 2004. Lymphocyte trafficking across high endothelial venules: Dogmas and enigmas. Nat Rev Immunol 4: 360-370.
45. Morikawa S, Baluk P, Kaidoh T, Haskell A, Jain RK, McDonald DM. 2002. Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am J Pathol 160: 985-1000.
46. Nagy JA, Chang SH, Shih SC, Dvorak AM, Dvorak HF. 2010. Heterogeneity of the tumor vasculature. Semin Thromb Hemost 36: 321-331.
47. Nesse RM, Bergstrom CT, Ellison PT, Flier JS, Gluckman P, Govindaraju DR, Niethammer D, Omenn GS, Perlman RL, Schwartz MD, et al. 2009. Evolution in health and medicine Sackler Colloquium: Making evolutionary biology a basic science for medicine. Proc Natl Acad Sci 107: 1800-1807.
48. Nishio K, Suzuki Y, Aoki T, Suzuki K, Miyata A, Sato N, Naoki K, Kudo H, Tsumura H, Serizawa H, et al. 1998. Differential contribution of various adhesion molecules to leukocyte kinetics in pulmonary microvessels of hyperoxia-exposed rat lungs. Am J Respir Crit Care Med 157: 599-609.
49. Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, Hashimoto N, Furuse M, Tsukita S. 2003. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 161: 653-660.
50. Osterud B, Bajaj MS, Bajaj SP. 1995. Sites of tissue factor pathway inhibitor (TFPI) and tissue factor expression under physiologic and pathologic conditions. On behalf of the Subcommittee on Tissue factor Pathway Inhibitor (TFPI) of the Scientific and Standardization Committee of the ISTH. Thromb Haemost 73: 873-875.
51. Pasqualini R, Ruoslahti E. 1996. Organ targeting in vivo using phage display peptide libraries. Nature 380: 364-366.
52. Passerini AG, Polacek DC, Shi C, Francesco NM, Manduchi E, Grant GR, Pritchard WF, Powell S, Chang GY, Stoeckert CJ Jr., et al. 2004. Coexisting proinflammatory and antioxidative endothelial transcription profiles in a disturbed flow region of the adult porcine aorta. Proc Natl Acad Sci 101: 2482-2487.
53. Patten SG, Adamcic U, Lacombe K, Minhas K, Skowronski K, Coomber BL. 2010. VEGFR2 heterogeneity and response to anti-angiogenic low dose metronomic cyclophosphamide treatment. BMC Cancer 10: 683.
54. Petzelbauer P, Bender JR, Wilson J, Pober JS. 1993. Heterogeneity of dermal microvascular endothelial cell antigen expression and cytokine responsiveness in situ and in cell culture. J Immunol 151: 5062-5072.
55. Purhonen S, Palm J, Rossi D, Kaskenpaa N, Rajantie I, Yla-Herttuala S, AlitaloK, Weissman IL, Salven P. 2008. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Proc Natl Acad Sci 105: 6620-6625.
56. Ricci-Vitiani L, Pallini R, Biffoni M, Todaro M, Invernici G, Cenci T, Maira G, Parati EA, Stassi G, Larocca LM, et al. 2010. Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 468: 824-828.
57. Roberts WG, Delaat J, Nagane M, Huang S, Cavenee WK, Palade GE. 1998. Host microvasculature influence on tumor vascular morphology and endothelial gene expression. Am J Pathol 153: 1239-1248.
58. Rosenberg RD, Aird WC. 1999. Vascular-bed-specific hemostasis and hypercoagulable states. N Engl J Med 340: 1555-1564.
59. Ruoslahti E, Rajotte D. 2000. An address system in the vasculature of normal tissues and tumors. Annu Rev Immunol 18: 813-827.
60. Sato Y. 2011. Persistent vascular normalization as an alternative goal of anti-angiogenic cancer therapy. Cancer Sci 102: 1253-1256.
61. Seaman S, Stevens J, Yang MY, Logsdon D, Graff-Cherry C, St Croix B. 2007. Genes that distinguish physiological and pathological angiogenesis. Cancer Cell 11: 539-554.
62. Simionescu M, Gafencu A, Antohe F. 2002. Transcytosis of plasma macromolecules in endothelial cells: A cell biological survey. Microsc Res Tech 57: 269-288.
63. Simonson AB, Schnitzer JE. 2007. Vascular proteomic mapping in vivo. J Thromb Haemost 5 (Suppl 1): 183-187.
64. Springer TA. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 76: 301-314.
65. Stafford JH, Thorpe PE. 2011. Increased exposure of phosphatidylethanolamine on the surface of tumor vascular endothelium. Neoplasia 13: 299-308.
66. Tinbergen N. 1963. On aims and methods in ethology. Z Tierpsychol 20: 410-433.
67. Unger RE, Oltrogge JB, von Briesen H, Engelhardt B, Woelki U, Schlote W, Lorenz R, Bratzke H, Kirkpatrick CJ. 2002. Isolation and molecular characterization of brain microvascular endothelial cells from human brain tumors. In Vitro Cell Dev Biol Anim 38: 273-281.
68. Wang HW, Trotter MW, Lagos D, Bourboulia D, Henderson S, Makinen T, Elliman S, Flanagan AM, Alitalo K, Boshoff C. 2004. Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat Genet 36: 687-693.
69. Wisse E. 1970. An electron microscopic study of the fenestrated endothelial lining of rat liver sinusoids. J Ultrastruct Res 31: 125-150.
70. Wong J, Johnston B, Lee SS, Bullard DC, Smith CW, Beaudet AL, Kubes P. 1997. A minimal role for selectins in the recruitment of leukocytes into the inflamed liver microvasculature. J Clin Invest 99: 2782-2790.
71. Yano K, Gale D, Massberg S, Cheruvu PK, Monahan-Earley R, Morgan ES, HaigD, von Andrian UH, Dvorak AM, Aird WC. 2007. Phenotypic heterogeneity is an evolutionarily conserved feature of the endothelium. Blood 109: 613-615.
72. Zhang J, Burridge KA, Friedman MH. 2008. In vivo differences between endothelial transcriptional profiles of coronary and iliac arteries revealed by microarray analysis. Am J Physiol Heart Circ Physiol 295: H1556-H1561.